Weill Neurohub
September 26, 2022
UW joins industry-academia alliance to accelerate research in neuroscience
The University of Washington has joined the Alliance for Therapies in Neuroscience (ATN), a long-term research partnership between academia and industry geared to transform the fight against brain diseases and disorders of the central nervous system. Launched in 2021 by the University of California, San Francisco, UC Berkeley, Genentech — a member of the Roche group — and Roche Holding AG, the ATN seeks to accelerate the development of new therapies for a broad range of brain and central nervous system conditions.
November 12, 2019
New Weill Neurohub will unite UCSF, UC Berkeley, UW in race to find new treatments for brain diseases
With a $106 million gift from the Weill Family Foundation, UC Berkeley, UC San Francisco and the University of Washington have launched the Weill Neurohub, an innovative research network that will forge and nurture new collaborations between neuroscientists and researchers working in an array of other disciplines — including engineering, computer science, physics, chemistry and mathematics — to speed the development of new therapies for diseases and disorders that affect the brain and nervous system.
